Synopsis of recent research by authors named "Emma Beltran"
- Emma Beltran's recent research focuses on evaluating the effectiveness, safety, and survival of various biologic therapies in treating chronic inflammatory conditions, particularly psoriasis and related arthritic disorders, in real-world clinical settings in Spain.
- Key findings highlight the practicality and efficacy of dual targeted therapy for refractory psoriatic arthritis and spondyloarthritis, as well as the comparative effectiveness of anti-TNF therapy versus tocilizumab for managing refractory cystoid macular edema associated with Behçet's disease.
- Beltran's work also addresses broader healthcare implications, such as sustainability in agricultural practices through nitrogen flow analysis, alongside meticulous studies on treatment outcomes for ocular and neurological manifestations of Behçet's disease, showcasing a comprehensive approach to both dermatological and systemic autoimmune conditions.
